Resolvin D1 shows osseous-protection via RANK reduction on monocytes during orthodontic tooth movement

6Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The study aimed to investigate the role of RvD1 in acute and prolonged sterile inflammation and bone remodeling. A mouse model of sterile inflammation that involves bone resorption was used to examine endogenous RvD1 kinetics during inflammation. Application of exogenous RvD1 significantly inhibited bone remodeling via osteoclast reduction, alongside an anti-inflammatory secretome shift, increased macrophages recruitment and reduction of T-cytotoxic cells. In vitro and in vivo, RvD1 led to significant reduction in RANK expression which reduce osteoclastogenesis in a dose-dependent manner. Taken together, the data shows a dual role for RvD1, as a potent immunoresolvent agent alongside an osteoresolvent role, showing a potential therapeutic agent in bone resorption associated inflammatory conditions.

Cite

CITATION STYLE

APA

Klein, Y., Levin-Talmor, O., Berkstein, J. G., Wald, S., Meirow, Y., Maimon, A., … Chaushu, S. (2022). Resolvin D1 shows osseous-protection via RANK reduction on monocytes during orthodontic tooth movement. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.928132

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free